Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19

Detalles Bibliográficos
Autores principales: Rothlin, Rodolfo Pedro, Pelorosso, Facundo Germán, Duarte, Mariano, Nicolosi, Liliana, Ignacio, Fernandez Criado, Salgado, María Victoria, Vetulli, Héctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086312/
https://www.ncbi.nlm.nih.gov/pubmed/37038324
http://dx.doi.org/10.1002/prp2.1083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086312/
https://www.ncbi.nlm.nih.gov/pubmed/37038324
http://dx.doi.org/10.1002/prp2.1083

Ejemplares similares